Sign In
Buy RMD
$188.63
+2.34 (+1.26%)
At Close: Jun 18, 2026
Resmed Q4 Earnings & Revenues Beat Estimates, Stock Up, Margins Climb
08:55am, Friday, 01'st Aug 2025
RMD tops Q4 earnings and revenue estimates with double-digit growth, rising margins and strong global device demand.
ResMed Inc. (RMD) Q4 2025 Earnings Call Transcript
09:39pm, Thursday, 31'st Jul 2025
ResMed Inc. (NYSE:RMD ) Q4 2025 Earnings Conference Call July 31, 2025 4:30 PM ET Company Participants Brett A. Sandercock - Chief Financial Officer Michael J.
Here's What Key Metrics Tell Us About ResMed (RMD) Q4 Earnings
07:01pm, Thursday, 31'st Jul 2025
The headline numbers for ResMed (RMD) give insight into how the company performed in the quarter ended June 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates a
ResMed (RMD) Surpasses Q4 Earnings and Revenue Estimates
06:20pm, Thursday, 31'st Jul 2025
ResMed (RMD) came out with quarterly earnings of $2.55 per share, beating the Zacks Consensus Estimate of $2.46 per share. This compares to earnings of $2.08 per share a year ago.
Resmed beats quarterly profit estimates on strong demand for sleep devices
04:53pm, Thursday, 31'st Jul 2025
Resmed beat Wall Street estimates for fourth-quarter profit on Thursday, driven by strong demand for its devices used to manage sleep apnea.
Resmed Inc. Announces Results for the Fourth Quarter of Fiscal Year 2025
04:05pm, Thursday, 31'st Jul 2025
Note: A webcast of Resmed's conference call will be available at 4:30 p.m. ET today at http://investor.resmed.com
Spot Outliers Like ResMed Early with Money Flows
06:08am, Wednesday, 30'th Jul 2025
ResMed, Inc. (RMD) shares up almost 3,142% since first Big Money outlier signal in 2000.
Will ResMed (RMD) Beat Estimates Again in Its Next Earnings Report?
01:10pm, Thursday, 24'th Jul 2025
ResMed (RMD) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
ResMed (RMD) Reports Next Week: Wall Street Expects Earnings Growth
11:08am, Thursday, 24'th Jul 2025
ResMed (RMD) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
ResMed Inc. (RMD) Hit a 52 Week High, Can the Run Continue?
10:16am, Wednesday, 23'rd Jul 2025
ResMed (RMD) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
Buy These 5 Low-Leverage Stocks Amid Impressive Retail Sales Data
11:26am, Friday, 18'th Jul 2025
With retail sales rebounding and Wall Street gaining, low-leverage stocks like NVS, RMD, WAB, ESLT and INGR offer scope for upside.
Top 15 High-Growth Dividend Stocks For July 2025
09:02pm, Tuesday, 01'st Jul 2025
My Top 15 High-Growth Dividend Stocks outperformed SPY and VIG in June, gaining 6.15% versus SPY's 5.14% and VIG's 3.41%. The list's year-to-date return is 12.59%, beating SPY every month in 2025, tho
Resmed to Report Fourth Quarter Fiscal 2025 Earnings on July 31, 2025
04:05pm, Tuesday, 01'st Jul 2025
SAN DIEGO, July 01, 2025 (GLOBE NEWSWIRE) -- Resmed (NYSE: RMD, ASX: RMD) today announced it plans to release financial and operational results for the fourth quarter of fiscal year 2025 on Thursday,
All You Need to Know About ResMed (RMD) Rating Upgrade to Buy
01:01pm, Wednesday, 25'th Jun 2025
ResMed (RMD) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).
Scoop Up These 4 GARP Stocks to Receive Handsome Returns
10:01am, Wednesday, 25'th Jun 2025
The GARP strategy helps investors gain exposure to stocks that have impressive prospects and are trading at a discount. SFM, ADBE, GE and RMD are some such stocks.
